[1] Fillmore HL,Van Meter TE,Broaddus WC.Membrane-type matrix metalloproteinases (MT-MMPs):expression and function during glioma invasion[J].J Neurooncol,2001,53(2):187-202.[2] Baker AH,George SJ,Zaltsman AB,et al.Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3[J].Br J Cancer,1999,79(9/10):1347-1355.[3] Aigner A.MicroRNAs (miRNAs) in cancer invasion and metastasis:therapeutic approaches based on metastasis-related miRNAs[J].J Mol Med,2011,89(5):445-457.[4] Li L,Li H.Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors[J].Cancer Biol Ther,2013,14(9):796-805.[5] Liu J,Shi W,Wu C,et al.miR-181b as a key regulator of the oncogenic process and its clinical implications in cancer[J].Biomed Rep,2014,2(1):7-11.[6] Shi L,Cheng Z,Zhang J,et al.has-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells[J].Brain Res,2008,1236:185-193.[7] Slaby O,Lakomy R,Fadrus P,et al.MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients[J].Neoplasma,2010,57(3):264-269.[8] Abba M,Patil N,Allgayer H.MicroRNAs in the regulation of MMPs and metastasis[J].Cancers,2014,6(2):625-645.[9] Zarrabi K,Dufour A,Li J,et al.Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration[J].J Biol Chem,2011,286(38):33167-33177.[10] Ulasov I,Yi R,Guo D,et al.The emerging role of MMP14 in brain tumorigenesis and future therapeutics[J].Biochim Biophys Acta,2014,1846(1):113-120.[11] Lin H,Zhang Y,Wang H,et al.Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells[J].Cancer Gene Ther,2012,19(12):845-851.[12] Cruz-Munoz W,Khokha R.The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis[J].Crit Rev Clin Lab Sci,2008,45(3):291-338.[13] Anania MC,Sensi M,Radaelli E,et al.TIMP3 regulates migration,invasion and in vivo tumorigenicity of thyroid tumor cells[J].Oncogene,2011,30(27):3011-3023.[14] Shi ZM,Wang XF,Qian X,et al.MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas[J].RNA,2013,19(4):552-560.[15] Wang J,Sai K,Chen FR,et al.miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1[J].Cancer Chemother Pharmacol,2013,72(1):147-158.[16] Sun YC,Wang J,Guo CC,et al.MiR-181b sensitizes glioma cells to teniposide by targeting MDM2[J].BMC Cancer,2014,14:611-617.[17] She X,Yu Z,Cui Y,et al.miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells[J].Med Oncol,2014,31(4):892-901.[18] Wang B,Hsu SH,Majumder S,et al.TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3[J].Oncogene,2010,29(12):1787-1797.[19] Lu Y,Roy S,Nuovo G,et al.Anti-microRNA-222 (anti-miR-222) and-181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP-3 protein and modulating mitogenic signal[J].J Biol Chem,2011,286(49):42292-42302.[20] 温娜,唐泽波,金宏,等.五味子多糖对脑胶质瘤SHG-44细胞血管内皮生长因子表达水平的影响[J].中国老年学杂志,2014,34(24):7048-7049.[21] 郭成永,梁朝辉,魏可欣,等.解旋酶RECQ1和细胞核相关抗原Ki-67在脑胶质瘤组织中的表达及相关性[J].中国老年学杂志,2015,35(12):3259-3260. |